LAZZARICH, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 394
EU - Europa 372
AS - Asia 267
SA - Sud America 47
AF - Africa 5
OC - Oceania 1
Totale 1.086
Nazione #
US - Stati Uniti d'America 383
IE - Irlanda 91
RU - Federazione Russa 90
HK - Hong Kong 86
SG - Singapore 58
DE - Germania 57
CN - Cina 55
SE - Svezia 50
BR - Brasile 39
UA - Ucraina 33
VN - Vietnam 30
IN - India 19
GB - Regno Unito 14
FR - Francia 13
FI - Finlandia 12
CA - Canada 7
IR - Iran 5
IT - Italia 5
TR - Turchia 5
NL - Olanda 4
AR - Argentina 3
MX - Messico 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
ID - Indonesia 2
JP - Giappone 2
PY - Paraguay 2
ZA - Sudafrica 2
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
EC - Ecuador 1
HR - Croazia 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
TW - Taiwan 1
Totale 1.086
Città #
Dublin 90
Hong Kong 86
Jacksonville 66
San Jose 41
Wilmington 25
Beijing 24
Ashburn 23
Dearborn 19
Singapore 17
Los Angeles 13
Dallas 12
Bremen 11
Lauterbourg 11
Lawrence 11
Moscow 11
Princeton 11
Ho Chi Minh City 9
San Mateo 9
Ann Arbor 6
Orem 6
Chandler 5
Hanoi 5
New York 5
Ankara 4
Chicago 4
Poplar 4
São Paulo 4
Buffalo 3
Denver 3
Glasgow 3
Redondo Beach 3
Santa Clara 3
Toronto 3
Zanjan 3
Amsterdam 2
Atlanta 2
Barnet 2
Chennai 2
Fairfield 2
Guangzhou 2
Guarulhos 2
Jakarta 2
Johannesburg 2
Mexico City 2
Montreal 2
Munich 2
New Delhi 2
Novara 2
Phoenix 2
Salvador 2
Stockholm 2
Ahmedabad 1
Alfenas 1
Algiers 1
Alvorada 1
Annapolis 1
Araçatuba 1
Ardabil 1
Asunción 1
Augusta 1
Balneário Arroio do Silva 1
Batna City 1
Berazategui 1
Biên Hòa 1
Brasília 1
Brooklyn 1
Brumadinho 1
Bến Tre 1
Camaçari 1
Campinas 1
Canoas 1
Catanduva 1
Changzhou 1
City of London 1
Cleveland 1
Cotia 1
Cristinápolis 1
Da Nang 1
Dhaka 1
Dubai 1
Espoo 1
Faisalabad 1
Fuzhou 1
Goiânia 1
Haiphong 1
Hangzhou 1
Huế 1
Iracemápolis 1
Istanbul 1
Jaipur 1
Jinan 1
Kashiwazaki 1
Kunming 1
Libertad 1
Lima 1
London 1
Lấp Vò 1
Maceió 1
Meizhou 1
Meknes 1
Totale 636
Nome #
Prophylactic perioperative plasmapheresis does not prevent rebound of permeability factors in patients with focal segmental glomerulosclerosis (FSGS) who undergo kidney transplant. 128
Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy. 116
Warning: standard doses of low molecular weight heparin exceed the upper threshold of the anti-Xa range according to the degree of renal failure. 113
Anti-phospholipid nephropathy only belongs to Myakis I and IIA classes, always in association with lupus anticoagulant, but never anti-b(2)GP1 antibodies. 106
Clinical hypothesis predicts renal pathology in 67% of renal diseases: a 30-year experience on 1288 renal biopsies. 101
Risk factors for kidney graft loss: the role of HCV infection in 400 consecutive cases. 101
MGUS in renal transplant: still a matter of conern? 98
Why have outcomes of lupus nephritis been improving over the last 40 years? A monocentric experience. 89
Is plamapheresis effective to prevent FSGS recurrence on transplanted kidney? 86
Unexpectedly high prevalence of critic coronary artery disease in asymptomatic dialysis patients screened for transplant wait list. 81
Conversion to rapamycin in renal transplanted patients who develop cancer: preliminary observation on a monocentric experience. 78
Totale 1.097
Categoria #
all - tutte 4.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 1 11 0
2021/202258 3 1 8 4 6 0 0 2 4 3 14 13
2022/2023190 13 8 15 0 12 12 0 14 99 0 12 5
2023/2024126 5 7 6 2 11 0 64 1 0 0 21 9
2024/202572 1 0 3 3 11 2 0 11 18 11 1 11
2025/2026420 24 9 39 102 51 34 63 56 14 28 0 0
Totale 1.097